MedPath

Xenothera SAS

Xenothera SAS logo
🇫🇷France
Ownership
Holding
Established
2014-01-01
Employees
1
Market Cap
-
Website
http://www.xenothera.com

Polyspecific Antibodies in Lymphoproliferative T-cell Disorders

Phase 1
Recruiting
Conditions
Peripheral T Cells Lymphoma (PTCL)
Interventions
First Posted Date
2024-07-11
Last Posted Date
2025-01-24
Lead Sponsor
Xenothera SAS
Target Recruit Count
54
Registration Number
NCT06495723
Locations
🇫🇷

CHU de Caen, Caen, France

🇫🇷

CHU de Clermont-Ferrand, Clermont-Ferrand, France

🇫🇷

CHU Henri-Mondor, Créteil, France

and more 4 locations

FIH XON7 in Advanced/Metastatic Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumor
Metastatic Cancer
Interventions
First Posted Date
2023-12-04
Last Posted Date
2025-04-06
Lead Sponsor
Xenothera SAS
Target Recruit Count
255
Registration Number
NCT06154291
Locations
🇧🇪

Institut Jules Bordet, Anderlecht, Belgium

🇫🇷

Hôpital Foch, Suresnes, France

🇫🇷

Centre Léon Bérard, Lyon, France

and more 1 locations

A First-in-Human Study With XAB05 in Healthy Subjects

Phase 1
Completed
Conditions
Infection, Bacterial
Interventions
Biological: Experimental
First Posted Date
2022-04-01
Last Posted Date
2022-08-12
Lead Sponsor
Xenothera SAS
Target Recruit Count
25
Registration Number
NCT05307406
Locations
🇳🇱

QPS Netherlands B.V., Groningen, Netherlands

Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Phase 2
Terminated
Conditions
COVID-19
Interventions
Drug: Placebo
First Posted Date
2021-06-16
Last Posted Date
2023-01-23
Lead Sponsor
Xenothera SAS
Target Recruit Count
290
Registration Number
NCT04928430
Locations
🇧🇬

Complex Oncological Center - Ruse Ltd, COVID Departement, Ruse, Bulgaria

🇬🇷

Evangelismos General Hospital of Athens, Critical Care Departement, Athens, Greece

🇬🇷

"Sotiria" General Hospital of Chest Diseases of Athens, 3rd Department of Medicine of University of Athens, Athens, Greece

and more 15 locations

First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

Phase 1
Completed
Conditions
Kidney Transplant
Interventions
Biological: LIS1
First Posted Date
2020-06-16
Last Posted Date
2022-08-17
Lead Sponsor
Xenothera SAS
Target Recruit Count
10
Registration Number
NCT04431219
Locations
🇨🇿

Institut klinické a experimentální medicíny, Praha 4, Czechia

© Copyright 2025. All Rights Reserved by MedPath